Cutting Edge MarinBio Science Newsletter

Looking for a partner with 30 years of proven expertise in taking drugs from development to validation and FDA approval?
Contact us @ 415.883.8000

Marin Biologic Laboratories official logo, representing their expertise in custom assay development and FDA registered contract laboratory services.

Evaluating Immunogenicity in AAV-Based Treatments

Immunogenicity assays are designed to determine the immune response to biotherapeutics such as protein, peptide, antibody, oligonucleotide or DNA/RNA-based drugs and its clinical impact. In a recent IQ Consortium industry white paper published in the journal Molecular Therapy, researchers provided a framework for bioanalytical strategies related to the immunogenicity assessment of recombinant adenovirus associated virus….

Recent Articles